-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
7 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$18,960 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$2.71 M
Tarsus Pharmaceuticals, Inc. Insider Transactions
Tarsus Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Farrow Jeffrey S
See Remarks |
Sell | 10,445 @ $27.47 | $286,924 | 18,136 | 06/18/2024 | 06/20/2024 | |
|
Mottiwala Aziz
Chief Commercial Officer |
Sell | 4,766 @ $30.60 | $145,840 | 54,075 | 03/18/2024 | 03/19/2024 | |
|
Wahl Bryan
General Counsel |
Sell | 4,436 @ $30.60 | $135,742 | 40,951 | 03/18/2024 | 03/19/2024 | |
|
Azamian Bobak R.
CEO |
Sell | 10,415 @ $30.60 | $318,699 | 26,456 | 03/18/2024 | 03/19/2024 | |
|
Whitfield Dianne C.
Chief Human Resources Officer |
Sell | 4,314 @ $30.60 | $132,008 | 34,181 | 03/18/2024 | 03/19/2024 | |
| Sell | 4,879 @ $30.60 | $149,297 | 64,767 | 03/18/2024 | 03/19/2024 | ||
|
Azamian Bobak R.
CEO |
Sell | 8,000 @ $20.22 | $161,760 | 830,106 | 12/27/2023 | 12/29/2023 | |
|
Trevejo Jose M.
CHIEF MEDICAL OFFICER |
Sell | 2,252 @ $20.00 | $45,040 | 2,251 | 12/20/2023 | 12/22/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 9,443 @ $19.96 | $188,482 | 868,663 | 12/20/2023 | 12/22/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 30,557 @ $20.36 | $622,141 | 838,106 | 12/20/2023 | 12/22/2023 | |
|
Goldberg Andrew D.
Director |
Buy | 1,000 @ $18.96 | $18,960 | 3,000 | 12/15/2023 | 12/19/2023 | |
|
Whitfield Dianne C.
Chief Human Resources Officer |
Sell | 8,355 @ $16.31 | $136,270 | 26,784 | 11/30/2023 | 12/01/2023 | |
|
Wahl Bryan
General Counsel |
Sell | 8,356 @ $16.31 | $136,286 | 31,966 | 11/30/2023 | 12/01/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 2,896 @ $18.01 | $52,157 | 883,210 | 11/15/2023 | 11/17/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 4,904 @ $18.54 | $90,920 | 878,306 | 11/15/2023 | 11/17/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 200 @ $19.28 | $3,856 | 878,106 | 11/15/2023 | 11/17/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 8,000 @ $13.24 | $105,920 | 886,106 | 10/18/2023 | 10/20/2023 | |
|
Trevejo Jose M.
CHIEF MEDICAL OFFICER |
Sell | 1,604 @ $18.00 | $28,872 | 4,503 | 10/05/2023 | 10/06/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 8,000 @ $17.21 | $137,680 | 894,106 | 09/20/2023 | 09/22/2023 | |
|
Azamian Bobak R.
CEO |
Sell | 8,000 @ $17.23 | $137,840 | 902,106 | 08/23/2023 | 08/25/2023 |
Tarsus Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Tarsus Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Tarsus Pharmaceuticals, Inc. includes Azamian Bobak R., Wahl Bryan, Whitfield Dianne C., Goldberg Andrew D., Trevejo Jose M., Neervannan Seshadri, Mottiwala Aziz, Farrow Jeffrey S.
-
How much insider selling is happening at Tarsus Pharmaceuticals, Inc.?
Insiders have sold a total of 122,218 Tarsus Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.71 M sold.
-
Which Tarsus Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Tarsus Pharmaceuticals, Inc. shares in the last 12 months: Azamian Bobak R. ($1.54 M), Wahl Bryan ($272,028), Whitfield Dianne C. ($268,278), Trevejo Jose M. ($45,040), Neervannan Seshadri ($149,297), Mottiwala Aziz ($145,840), Farrow Jeffrey S ($286,924),
-
How much insider buying is happening at Tarsus Pharmaceuticals, Inc.?
Insiders have purchased a total of 1,000 Tarsus Pharmaceuticals, Inc. shares in the last 12 months for a total of 18,960 sold.
-
Which Tarsus Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased Tarsus Pharmaceuticals, Inc. shares in the last 12 months: Goldberg Andrew D. ($18,960),